MIT BOTULINUMTOXIN VORGEFÜLLTER BEHÄLTER

European patent · EP3590500 · In force

Register entry

Publication number
EP3590500
Application number
EP19193112
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Dec 22, 2015
Published
Jan 8, 2020
Granted
Jun 25, 2025
Protection ends at the latest
Dec 21, 2035
Next annual fee due
Dec 31, 2026
IPC classes
A61K 8/64 (2006.01)
A61K 47/42 (2017.01)
A61P 17/00 (2006.01)
A61P 31/04 (2006.01)
A61M 5/31 (2006.01)
A61M 5/315 (2006.01)
A61K 9/00 (2006.01)
A61K 47/26 (2006.01)
A61Q 19/08 (2006.01)
A61K 38/48 (2006.01)
Priority
EP 14004394 23.12.2014
Divided from
EP15823134
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. May 7, 2026

    Change

    Published in Swissreg on 07.05.2026

  2. Jan 1, 2026

    Change

    Published in Swissreg on 01.01.2026

  3. Jun 25, 2025

    Granted

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 25.06.2025

Parties

Holder

Merz Pharma GmbH & Co. KGaA

Eckenheimer Landstrasse 100, 60318 Frankfurt am Main, DE

Inventor

VOGT, Markus

60438 Frankfurt am Main, DE

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.